- Home
- Cardiology
- Medx Weekly: Mitochondrial Disease Breakthrough, Pediatric IBS-C, Diabetes Advances
3mo3 min read
Medical Article
Hello, and a warm welcome to MedX, where we bring you the latest news and insights from the world of medicine. FDA Approval for Thymidine Kinase 2 Deficiency Treatment The FDA has approved doxecitine and doxribtimine, marking the first approved therapy for thymidine kinase 2 deficiency (TK2d) in adults and pediatric patients with symptom onset at
Medx Weekly: Mitochondrial Disease Breakthrough, Pediatric IBS-C, Diabetes Advances
4734 Reached12 Comments
Similar Content

Characteristics, Outcomes and Predictors of Long-Term Mortality for Patients Hospitalized for Acute Heart Failure
150 Reached

ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes

Catheter Ablation for Atrial Fibrillation with HF
691 Reached

Single-incision Laparoscopy for Gastrostomy
412 Reached2 Comments1 Likes

Intestinal Obstruction and Ileocolic Fistula due to Gossypiboma
865 Reached30 Comments15 Likes
